4th Quarter - Report — FAEGRE DRINKER BIDDLE & REATH LLP for SPINA BIFIDA ASSOCIATION (2011)

Firm

FAEGRE DRINKER BIDDLE & REATH LLP

Client

SPINA BIFIDA ASSOCIATION

Income

$40,000

Expenses

—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health Care Reform Implementation.

Lobbyist	Covered position, as disclosed
ANDREW BOWMAN	—
ILISA HALPERN PAUL	—
HILARY HANSEN	—
JEREMY SCOTT	—

Contacted: SENATE; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Food Industry (safety, labeling, etc.) FOO

Folic Acid Fortification

Lobbyist	Covered position, as disclosed
ILISA HALPERN PAUL	—
HILARY HANSEN	—
JEREMY SCOTT	—

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Medical/Disease Research/Clinical Labs MED

Spina Bifida Research and Awareness and Access to Care; Medical Device User Fee Act; Folic Acid Fortification

Lobbyist	Covered position, as disclosed
ILISA HALPERN PAUL	—
HILARY HANSEN	—
JEREMY SCOTT	—

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Budget/Appropriations BUD

FY 2012 Labor, Health and Human Services, and Education and Related Agencies Appropriations; Consolidation Appropriations Act (H.R. 2055).

Lobbyist	Covered position, as disclosed
ANDREW BOWMAN	—
ILISA HALPERN PAUL	—
HILARY HANSEN	—
JEREMY SCOTT	—

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Bills named: H.R. 2055 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.